Coronary heart disease
186 results
1 - 100
Antibiotics for secondary prevention of coronary heart disease- Psychological interventions for coronary heart disease
- Exercise‐based cardiac rehabilitation for coronary heart disease
- Patient education in the management of coronary heart disease
- Interventions to support return to work for people with coronary heart disease
- Coronary artery bypass surgery versus medical therapy alone for ischaemic heart disease
- Psychological interventions for depression and anxiety in patients with coronary heart disease, heart failure or atrial fibrillation
- Music for stress and anxiety reduction in coronary heart disease patients
- Psychosocial interventions for smoking cessation in patients with coronary heart disease
- Yoga for secondary prevention of coronary heart disease: Cochrane systematic review
- Xiongshao for restenosis after percutaneous coronary intervention in patients with coronary heart disease: Cochrane systematic review
- Tong-xin-luo capsule for patients with coronary heart disease after percutaneous coronary intervention: Cochrane systematic review
- Smoking cessation for the secondary prevention of coronary heart disease: Cochrane systematic review
- Internet‐based interventions for the secondary prevention of coronary heart disease
- Multiple risk factor interventions for primary prevention of coronary heart disease: Cochrane systematic review
- Off-pump versus on-pump coronary artery bypass grafting for ischaemic heart disease: Cochrane systematic review
- Preoperative coronary interventions for preventing acute myocardial infarction in the perioperative period of major open vascular or endovascular surgery
- Complete versus culprit‐only revascularisation in ST elevation myocardial infarction with multi‐vessel disease
- Omega‐3 fatty acids for the primary and secondary prevention of cardiovascular disease
- Transradial versus transfemoral approach for diagnostic coronary angiography and percutaneous coronary intervention in people with coronary artery disease
- Statins for acute coronary syndrome
- Salicylate for the treatment of Kawasaki disease in children
- Polyunsaturated fatty acids for the primary and secondary prevention of cardiovascular disease
- Psychological and pharmacological interventions for depression in patients with coronary artery disease
- Intravenous immunoglobulin for the treatment of Kawasaki disease in children
- Drug‐eluting stents versus bare‐metal stents for acute coronary syndrome
- Intravenous immunoglobulin for the treatment of Kawasaki disease
- Chelation therapy for atherosclerotic cardiovascular disease
- Ezetimibe for the prevention of cardiovascular disease and all‐cause mortality events
- Stem cell therapy for chronic ischaemic heart disease and congestive heart failure
- Beta‐blockers for hypertension
- Hypothermia to reduce neurological damage following coronary artery bypass surgery: Cochrane systematic review
- Platelet glycoprotein IIb/IIIa blockers during percutaneous coronary intervention and as the initial medical treatment of non-ST segment elevation acute coronary syndromes: Cochrane systematic review
- Exercise‐based cardiac rehabilitation for adults with stable angina
- First‐line drugs for hypertension
- Drug-eluting stents versus bare metal stents for angina or acute coronary syndromes: Cochrane systematic review
- Cardioselective beta‐blockers for chronic obstructive pulmonary disease
- Beta blockers for peripheral arterial disease: Cochrane systematic review
- Carotid endarterectomy for carotid stenosis in patients selected for coronary artery bypass graft surgery
- Cardiac rehabilitation for people with heart disease: an overview of Cochrane systematic reviews
- Clopidogrel plus aspirin versus aspirin alone for preventing cardiovascular events
- Cardioselective beta‐blockers for reversible airway disease
- Omega‐6 fats for the primary and secondary prevention of cardiovascular disease
- Corticosteroids for the treatment of Kawasaki disease in children
- Pharmacotherapy for mild hypertension
- Smoking cessation for secondary prevention of cardiovascular disease
- Percutaneous transluminal rotational atherectomy for coronary artery disease
- Interventions for promoting physical activity: Cochrane systematic review
- Diuretics for heart failure: Cochrane systematic review
- Social network interventions to support cardiac rehabilitation and secondary prevention in the management of people with heart disease
- Remote ischaemic preconditioning for coronary artery bypass grafting (with or without valve surgery): Cochrane systematic review
- Oestrogen therapy for urinary incontinence in post‐menopausal women
- Pain relief for the removal of femoral sheath after percutaneous coronary intervention
- Fibrates for secondary prevention of cardiovascular disease and stroke
- Celecoxib for osteoarthritis
- Pharmacotherapy for hypertension in adults aged 18 to 59 years
- Colchicine for prevention of cardiovascular events
- Systematic versus opportunistic risk assessment for the primary prevention of cardiovascular disease
- Pharmacotherapy for hypertension in adults 60 years or older
- Steroid sex hormones for lower limb atherosclerosis